We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click ...
Shares of Elevance Health Inc. ELV slipped 1.42% to $405.40 Tuesday, on what proved to be an all-around great trading session ...
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $492.5, with a ...
In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...
Elevance Health Inc. closed 27.50% below its 52-week high of $567.26, which the company achieved on September 3rd.
According to Benzinga Pro, Elevance Health's peer group average for short interest as a percentage of float is 5.53%, which ...
Analyst David Windley from Jefferies maintained a Buy rating on Elevance Health (ELV – Research Report) and increased the price target to ...
In general, value stocks tend to be those of mature companies that are growing relatively slowly and that pay dividends. Growth stocks are those of rapidly growing companies that tend to trade at ...